- US-listed companies
- IDEXX LABORATORIES INC
- Balance sheet
IDEXX LABORATORIES INC (IDXX) Balance sheet
Market cap
$45.8B
P/E ratio
| 2010/12 | 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 157 | 184 | 224 | 279 | 323 | 129 | 155 | 188 | 124 | 90 | 384 | 144 | 113 | 454 | 288 |
| Marketable securities, current | - | - | - | - | - | 214 | 237 | 284 | - | - | - | - | - | - | - |
| Total cash & short-term investments | 157 | 184 | 224 | 279 | 323 | 343 | 392 | 472 | 124 | 90 | 384 | 144 | 113 | 454 | 288 |
| Accounts receivable, net | 120 | 141 | 138 | 158 | 152 | 188 | 204 | 235 | 249 | 269 | 331 | 368 | 401 | 457 | 474 |
| Inventories | 128 | 133 | 141 | 133 | 160 | 189 | 158 | 164 | 173 | 195 | 210 | 269 | 368 | 380 | 382 |
| Total current assets | 461 | 524 | 570 | 653 | 759 | 822 | 846 | 972 | 654 | 680 | 1,063 | 956 | 1,101 | 1,495 | 1,400 |
| Property, plant and equipment, net | 202 | 217 | 245 | 281 | 304 | 333 | 357 | 379 | 437 | 534 | 555 | 588 | 649 | 702 | 713 |
| Total non-current assets | 437 | 507 | 534 | 578 | 625 | 653 | 685 | 741 | 883 | 1,153 | 1,232 | 1,482 | 1,645 | 1,765 | 1,894 |
| Total assets | 897 | 1,031 | 1,104 | 1,231 | 1,384 | 1,475 | 1,531 | 1,713 | 1,537 | 1,832 | 2,295 | 2,437 | 2,747 | 3,260 | 3,293 |
| Accounts payable | 23 | 37 | 35 | 30 | 45 | 53 | 60 | 67 | 70 | 72 | 75 | 116 | 110 | 111 | 114 |
| Long-term debt, current | - | - | - | - | - | - | - | - | - | - | 50 | 75 | 75 | 75 | 168 |
| Total current liabilities | 285 | 437 | 406 | 478 | 821 | 857 | 935 | 1,005 | 770 | 725 | 583 | 764 | 1,236 | 952 | 1,068 |
| Long-term debt, non-current | - | - | - | - | - | - | - | - | - | - | 858 | 775 | 694 | 623 | 450 |
| Total non-current liabilities | 38 | 54 | 61 | 234 | 446 | 702 | 704 | 763 | 776 | 929 | 1,079 | 984 | 902 | 824 | 630 |
| Total liabilities | 323 | 491 | 467 | 712 | 1,267 | 1,559 | 1,639 | 1,767 | 1,547 | 1,655 | 1,662 | 1,747 | 2,138 | 1,775 | 1,698 |
| Common stock and paid-in capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Retained earnings | 966 | 1,127 | 1,306 | 1,493 | 1,675 | 318 | 540 | 804 | 1,168 | 1,596 | 2,176 | 2,920 | 3,600 | 4,445 | 5,332 |
| Stockholders' equity | 574 | 540 | 636 | 518 | 118 | -84 | -108 | -54 | -9 | 178 | 633 | 690 | 609 | 1,485 | 1,595 |
| Total debt | - | - | - | - | - | - | - | - | - | - | 908 | 850 | 769 | 698 | 618 |
| Net debt | - | - | - | - | - | - | - | - | - | - | 525 | 706 | 657 | 244 | 329 |
| D/E ratio (%) | - | - | - | - | - | - | - | - | - | - | 143.6 | 123.2 | 126.4 | 47 | 38.7 |
| Working capital |